One of the first compounds of this series was [18F]ML04, which although retained selectivity for EGFR was poorly specific 3 and polar surface area (PSA) 85 ?2 [23]

One of the first compounds of this series was [18F]ML04, which although retained selectivity for EGFR was poorly specific 3 and polar surface area (PSA) 85 ?2 [23]. of EGFR [14]. On the other hand [11C]erlotinib showed more promising results assessment of EGFR mutational status in NSCLC individuals have been published [16]. This small trial… Continue reading One of the first compounds of this series was [18F]ML04, which although retained selectivity for EGFR was poorly specific 3 and polar surface area (PSA) 85 ?2 [23]

Published
Categorized as Her